UTI Mid Cap Fund Direct Growth
Equity
Direct
Mid-Cap
NAV as on 03-01-2025
₹ 340.54
▲1%
1D
Inception Returns
20.5%
/yr
About UTI Mid Cap Fund Direct Growth
UTI Mid Cap Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Ankit Agarwal. The fund could potentially beat inflation in the long-run.
Key Parameters
- UTI Mid Cap Fund Direct Growth has ₹12029 Cr worth of assets under management (AUM) as on Nov 2024 and is more than category average.
- The fund has an expense ratio 0.9.
Returns
UTI Mid Cap Fund Direct Growth has given a CAGR return of 20.54% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 26.42%, 18.60% and 26.14% respectively.
Holdings
UTI Mid Cap Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Consumer Cyclical, Industrial, Financial Services, Tech, Health, Basic Materials, Communication, Real Estate, Consumer Defensive, Utilities, Energy. Its top holdings are Coforge Ltd, Persistent Systems Ltd, Phoenix Mills Ltd, Polycab India Ltd, PB Fintech Ltd
Taxation
As it is a mid-cap mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of UTI Mid Cap Fund Direct Growth
The objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of mid cap companies. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. UTI Mid Cap Fund Direct Growth has no lock in period.
Historical NAV & Returns
Annualised
▲
▼
2117 people have invested ₹ 2.7Cr in UTI Mid Cap Fund Direct Growth in the last three months
INDmoney Rank for UTI Mid Cap Fund Direct Growth
Powered by IND quant engine
15
/19
29% Performance
34% Risk Management
56% Cost
15 out of 19 among mid-cap
Beats FD returns for both 3Y & 5Y
3Y returns in the bottom 25% of the category
UTI Mid Cap Fund Direct Growth Overview
| Expense ratio | 0.89% |
Benchmark | S&P BSE Midcap TR INR |
| AUM | ₹12029 Cr |
| Inception Date | 1 January, 2013 |
| Min Lumpsum/SIP | ₹5000/₹500 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 36.32% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (03-Jan-25)
Fund Distribution
as on (30-Nov-24)
Mid cap
66.4%
Small cap
23%
Large cap
6.9%
Sector Allocation
Consumer Cyclical
19.9%
Industrial
18.5%
Financial Services
17.7%
Tech
13.1%
Health
11.1%
Basic Materials
9.8%
Communication
3.4%
Real Estate
2.2%
Consumer Defensive
2.2%
Utilities
1.8%
Energy
0.2%
All changes are between Sep'24 and Nov'24
- This fund’s returns stands at 1.04% whereas the fund’s underlying benchmark Nifty Midcap 150 returns stands at -0.54% as on Nov'24
- This fund outperformed Nifty Midcap 150 by 1.59% in Nov'24
- AUM of the fund stands at 12K Cr as of Nov'24
- AUM increased by 134.6 Cr between Nov'24 and Oct'24
Top Stocks bought last month
Polycab India Ltd's allocation increased from 1.89% to 2.1%
Phoenix Mills Ltd's allocation increased from 2.01% to 2.16%
Dixon Technologies (India) Ltd's allocation increased from 1.33% to 1.48%
Top Stocks sold last month
Persistent Systems Ltd's allocation decreased from 2.28 % to 2.21 %
Alkem Laboratories Ltd's allocation decreased from 2.02 % to 1.9 %
Ajanta Pharma Ltd's allocation decreased from 1.88 % to 1.84 %
Mid Cap allocation has gone down from 66.4% to 66.4%
Large Cap allocation has gone up from 6.9% to 6.9%
Small Cap allocation has gone down from 23.5% to 23%
Cash allocation has gone up from 3% to 3.7%
Debt allocation has gone down from 0.1% to 0%
Top 3 Sectors in November were Consumer Cyclical, Industrial & Financial Services
Nov'24
Consumer Cyclical
20%
Industrial
19%
Financial Services
18%
Oct'24
Consumer Cyclical
20%
Industrial
19%
Financial Services
18%
Holdings | Weight% | 1M Change | |
|---|---|---|---|
 Coforge Ltd | 2.67% | -6.3% | |
 Persistent Systems Ltd | 2.21% | -0.2% | |
 Phoenix Mills Ltd | 2.16% | 0% | |
 Polycab India Ltd | 2.1% | 0% | |
 PB Fintech Ltd | 2.04% | -4.3% |
See all
Top Growth Drivers | 1M Return |
|---|---|
 Coforge Ltd | 10.5% |
PB Fintech Ltd | 9% |
 Persistent Systems Ltd | 8.5% |
Loading...
We are taking more time than usual
Ankit Agarwal
Fund Manager of UTI Mid Cap Fund Direct Growth, since 30 August 2019
Top funds managed
Fund House
UTI Asset Management Co Ltd
Total Schemes
Total AUM
₹2.36L Cr
as on 29-Nov-2024
Address
PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051
Phone
+912266786666
Website
service@uti.co.in
Mutual Fund Insights
This fund expense ratio is slightly on the lower side within the category (mid-cap). Its expense ratio is 0.89% which is lower than the category average expense ratio of 1.12%.
In the last 5 years, Motilal Oswal Midcap Direct Growth has given 35.1% return, outperforming this fund by 8.96% per annum.
Over the last 3 months, this fund has experienced a 4.9% drop in AUM moving from 12.64K Cr to 12.02K Cr.
In the last 1 year, Motilal Oswal Midcap Direct Growth has given 61.63% return, outperforming this fund by 35.21%.
In the last 3 years, Motilal Oswal Midcap Direct Growth has given 37.2% return, outperforming this fund by 18.6% per annum.
UTI Mid Cap Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 20.54% since inception which is more than its category average return of 19.55%
Fund Allocations
This fund has an allocation of 96.3% in Equity, 0% in Debt and 3.7% in Cash related instruments
AUM size ₹12029 Cr
This fund has AUM of ₹12029 Cr which is more than its category average of ₹ 9592 Cr
Expense Ratio 0.89%
This fund has an expense ratio of 0.89% which is less than its category average expense ratio of 1.35%
Frequently Asked Questions for UTI Mid Cap Fund Direct Growth
The current NAV of UTI Mid Cap Fund Direct Growth is ₹340.54 as on 03-Jan-2025.
Existing (Absolute + CAGR) as on 03-Jan-2025.
UTI Mid Cap Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 0.21% | 0.21% |
6 Month Returns | 3.86% | 3.86% |
1 Year Returns | 26.42% | 26.42% |
3 Years Returns | 66.81% | 18.6% |
5 Years Returns | 219.34% | 26.14% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.89% as on December 2024
₹12029 Cr as on December 2024
Coforge Ltd(2.67%), Persistent Systems Ltd(2.21%), Phoenix Mills Ltd(2.16%), Polycab India Ltd(2.1%), PB Fintech Ltd(2.04%) as on December 2024
Consumer Cyclical(19.15%), Industrial(17.86%), Financial Services(17.01%) as on December 2024
The alpha ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
UTI Mid Cap Fund Direct Growth | -0.31 | -2.65 | 0.46 |
As on December 2024
The alpha for UTI Mid Cap Fund Direct Growth is calculated against S&P BSE Midcap TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
UTI Mid Cap Fund Direct Growth | 1.02 | 0.88 | 0.88 |
As on December 2024
The Beta for UTI Mid Cap Fund Direct Growth is calculated with S&P BSE Midcap TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
UTI Mid Cap Fund Direct Growth | 1.15 | 0.81 | 1.02 |
As on December 2024
The sharpe ratio for UTI Mid Cap Fund Direct Growth is calculated with S&P BSE Midcap TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
UTI Mid Cap Fund Direct Growth | 14.06 | 14.33 | 19.63 |
As on December 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.49 as on December 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Ankit Agarwal is the fund manager of UTI Mid Cap Fund Direct Growth
The Exit load of UTI Mid Cap Fund Direct Growth is 1%